Fractyl Health, Inc. Common Stock (GUTS)
Healthcare
Biotechnology
0.69 $
-0.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Fractyl Health, Inc. Common Stock (GUTS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -90 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -28 | -31 | -33 | -46 | -43 | -66 | -90 | |
| 0.9 | 0.8 | 0.7 | 0.5 | 0.3 | 0.7 | 1.1 | |
| 2.5 | 1.6 | 2.1 | 3.1 | 4.3 | 14 | 6.7 | |
| -0.8 | -3.5 | 1.7 | -1.2 | 1.0 | 9.6 | -0.4 | |
| 0.1 | 0.0 | 0.1 | 0.1 | 0.4 | 1.8 | 0.6 | |
| -0.1 | 0.0 | -0.1 | -0.1 | – | -1.8 | -0.6 | |
| – | – | 0.0 | 4.0 | 28 | -0.2 | -0.5 | |
| 15 | 54 | 100 | 4.4 | 27 | 101 | 105 | |
| -13 | 23 | 66 | -46 | -16 | 34 | 14 | |
| -28 | -31 | -34 | -46 | -43 | -67 | -91 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.